Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 3Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 5Menorrhagia 1Endometriosis 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6Uterine Artery Embolization 5Norethindrone Acetate 5relugolix 4Uterine Myomectomy 3linzagolix 2Tranexamic Acid 2ziprasidone 1vilaprisan 1ulipristal 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Radiofrequency Ablation 1Progesterone 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Menorrhagia × vilaprisan × Clear all
NCT02465814 2016-11-22

ASTEROID 2

Bayer

Phase 2 Completed
120 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡